Press Releases
Cancer Patient Sues Big Pharma for Illegal Price Gouging
WASHINGTON, DC – A patient with incurable blood cancer filed a class action lawsuit against Celgene Corporation for abusing consumer safety rules and maintaining a monopoly over its high-cost cancer drugs. The suit alleges Celgene illegally blocked generic development for its highly effective drugs Thalomid and Revlimid—the latter of which costs more than $12,000 for […]